CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Roche, Ionis RNA drug scores in kidney disease study

Data ReadoutpositivePositive
AI Analysis

Summary

Roche and Ionis announced positive results from a clinical study of their RNA-based drug candidate for kidney disease. The positive outcome represents a meaningful advance in the development of this therapeutic approach.

Clinical Trial Data

Primary Endpoint

Met

Importance:7/10
Sentiment:
0.70
RNA therapykidney diseaseclinical trial
Related Companies

Read the original article

Published by yahoo_finance on September 23, 2026 4:21 PM

Read Original